Sandbox Reserved 430: Difference between revisions
From Proteopedia
Jump to navigationJump to search
No edit summary |
mNo edit summary |
||
| Line 73: | Line 73: | ||
==References== | ==References== | ||
<references/> | <references/> | ||
2. Savi, P., et al. "P2Y 12, a new platelet ADP receptor, target of clopidogrel." Biochemical and biophysical research communications 283.2 (2001): 379-383. | |||
3. Coon, Minor J. "Cytochrome P450: nature's most versatile biological catalyst." Annu. Rev. Pharmacol. Toxicol. 45 (2005): 1-25. | |||
4. Gurbel, Paul A., et al. "Clopidogrel for coronary stenting response variability, drug resistance, and the effect of pretreatment platelet reactivity." Circulation 107.23 (2003): 2908-2913. | |||
5. Barn, Kulpreet, and Steven R. Steinhubl. "A brief review of the past and future of platelet P2Y12 antagonist." Coronary artery disease 23.6 (2012): 368-374. | |||
6. Bodin, Philippe, and Geoffrey Burnstock. "Purinergic signalling: ATP release." Neurochemical research 26.8-9 (2001): 959-969. | |||